Clinical Guide to Antineoplastic Therapy

A Chemotherapy Handbook

Mary Gullatte (Redaktør) ; Rowena Schwartz (Redaktør) ; Katherine Spinks (Redaktør) ; Deborah Walker (Redaktør)

The landscape of cancer treatment is continually changing, with an increasing number of antineoplastic agents available. Beyond classical chemotherapy, treatment can involve multiple classes of therapies, such as immune check- point inhibitors, hormonal agents, small molecule inhibitors, and chimeric antigen receptor T-cell therapy. Les mer
Vår pris
3798,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 21 dager
På grunn av Brexit-tilpasninger og tiltak for å begrense covid-19 kan det dessverre oppstå forsinket levering.

Paperback
Legg i
Paperback
Legg i
Vår pris: 3798,-

(Paperback) Fri frakt!
Leveringstid: Sendes innen 21 dager
På grunn av Brexit-tilpasninger og tiltak for å begrense covid-19 kan det dessverre oppstå forsinket levering.

Om boka

The landscape of cancer treatment is continually changing, with an increasing number of antineoplastic agents available. Beyond classical chemotherapy, treatment can involve multiple classes of therapies, such as immune check- point inhibitors, hormonal agents, small molecule inhibitors, and chimeric antigen receptor T-cell therapy. This fourth edition of Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook provides a detailed overview of the mechanisms, side effects, and administration of myriad treatments to assist clinicians in providing comprehensive care to patients with cancer.

In addition to an expanded section of more than 200 drug monographs, this book covers essential topics related to cancer treatment, including venous access devices, complementary and alternative therapies, common treatment regimens, survivorship care, and stem cell transplantation.

This book is a must-have resource for clinicians in any care setting.

Fakta